Shaping the Future of Regenerative Medicine
Breast cancer is the most common cancer among women, with approximately 2.3 million new cases each year—affecting 1 in 8 women. In Europe, 60% of women undergoing mastectomy opt for reconstructive breast surgery, but existing methods are often but existing methods are often complex and require multiple surgeries or treatments.
In response to the critical need for safer, more effective, and natural breast reconstruction treatments following breast cancer treatment, 4Tissue's hydrogel tissue mimic technology promotes natural cell regeneration. Unlike traditional implants or flap surgeries, 4Tissue's minimally invasive, injectable solution supports the body's natural tissue regeneration process, delivering durable and predictable results.
Solutions for tissue regeneration
Focusing on the development of new aesthetic and medical solutions and therapies in the field of tissue reconstruction, tissue regeneration and anti-aging.
Research & development
Our multidisciplinary team of medical experts and senior scientists with expertise in resorbable biomaterials, cells and tissue engineering offers custom-made scientific services.
Internal development pipeline
We have an internal pipeline of products for soft tissue reconstruction, i.e. breast reconstruction, based on our proprietary toolbox of innovative polymers.
Co-development opportunities
Contact us if you are interested in initiating co-development programs, in licensing of our proprietary tissue mimics and injectable hydrogels, or if you are in need of custom-made solutions.
Developing solutions to overcome the limitations of current cell-based therapies